Cannara Biotech Inc. Reports Record Q3 2023 Financial Results

Cannara Biotech Inc. has announced its fiscal third quarter 2023 financial and operating results for the three- and nine-month periods ending May 31, 2023. The net revenues were $15.9 million and $39 .3 million, a 57% and 63% increase compared to the same periods of prior year. The company delivered its ninth consecutive quarter of positive Adjusted EBITDA of $3.9 million, a…

Read More

Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose

Gemina Laboratories Ltd. has announced another major innovation in lateral flow assay test design resulting from its innovative, patented Gemina Bridge chemistry platform. Gemina Labs has deployed cellulose (paper) test strips in the lateral flow assay format, a fully biodegradable, environmentally friendly alternative to the industry-standard nitrocellulose strip. Gemina Laboratories Ltd., a client of our…

Read More

Advanced Health Intelligence Ltd: Shareholder Update – FDA and Stellenbosch Study

Advanced Health Intelligence Ltd has provided a shareholder update regarding technology progress and the Stellenbosch University study. The shareholder update aims to offer detailed insight into the ongoing development, launch and release of their BHA, the company’s ground-breaking smartphone-based biometric health assessment. Further details explain the actions the company is taking to launch its robust,…

Read More